China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says
admin China’s top drug regulator said Friday that it approved Merck & Co.’s Molnupiravir for emergency…
Read Morelife sciences
Ex-Theranos exec ‘Sunny’ Balwani sentenced to nearly 13 years in prison
SAN JOSE, Calif. — A judge on Wednesday sentenced former Theranos executive Ramesh “Sunny” Balwani…
Read MoreBioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVI
By Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the…
Read More10 Dividend Aristocrat stocks expected by analysts to rise up to 54% in 2023
Stocks of companies that raise dividends consistently have outperformed during this year’s bear market. Below…
Read MoreElizabeth Holmes sentenced to over 11 years in prison for Theranos crimes
Theranos founder and former chief executive Elizabeth Holmes was sentenced to 135 months, or over…
Read MoreRoche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of…
Read MoreFTX’s stunning collapse nothing like Theranos, says venture investor and crypto bull Tim Draper
Tim Draper, founder and managing partner of Draper Associates and Draper University, balked at comparing…
Read MoreTrulieve issues cautious guidance ahead of key holiday season
Trulieve Cannabis Corp. posted a 34% increase in third-quarter revenue amid strength in its overall…
Read MoreAstraZeneca lifts guidance after forecast-beating profit and sales
AstraZeneca PLC on Thursday lifted its guidance for the full year after reporting a swing…
Read More
This fund beats the S&P 500 by using 75 of its stocks. Here’s how it works.
What worked well during the years-long bull market through 2021 — a focus on growth,…
Read More